Log in to save to my catalogue

Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with unco...

Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with unco...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4364857

Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes

Publication information

Publisher

Japan: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims/Introduction
Early initiation of basal insulin therapy is recommended for normalizing fasting blood glucose in type 2 diabetes mellitus. However, basal insulin treatment might not adequately control postprandial glucose levels. The present study evaluated whether the combination of the α‐glucosidase inhibitor, acarbose, and basal insulin im...

Alternative Titles

Full title

Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4364857

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4364857

Other Identifiers

ISSN

2040-1116

E-ISSN

2040-1124

DOI

10.1111/jdi.12261

How to access this item